Cardiovascular diseases represent the leading cause of deaths worldwide. Despite the permanent progress in the treatment of such conditions, targeted prevention approaches remain a key solution to address this issue.
 

This is the challenge that Imageens, a Paris-based startup led by Ted Baldwin, is tackling through the application of artificial intelligence to medical imaging, with the aim to quantify your arterial age.

This specific biomarker unvails unique opportunities to anticipate heart conditions for people at moderate risk, with the promise to inform better clinical care decisions.
 

We exchanged with Ted on the burden that cardiovascular diseases represent on a global level, the power of AI applied to medical imaging to discover early indicators of these pathologies, and how these insights can drive better personalized prevention programs to stay away from them.

​

What we also talked with Ted about:

• Assistance Publique - Hôpitaux de Paris (AP-HP)

• MESA trial

• Framingham risk score

• Cardiac CT calcium score

• Ascending aortic distensibility

• Ted’s TEDx presentation

• Ganymed Robotics

• Zoï

• Altos Labs

• Qualitiso
   

If you want to know more about Imageens, we invite you to consult their website.
 

You can contact Ted through LinkedIn or by email: tbaldwin@imageens.com
 

If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: m.chaffard05@gmail.com

And if you liked the episode, don’t hesitate to share it, subscribe to the podcast and leave a positive review on streaming platforms!